Incidence and prevalence of systemic sclerosis in Campo Grande, State of Mato Grosso do Sul, Brazil

被引:0
作者
Coelho Horimoto, Alex Magno [1 ,2 ,3 ]
Naka Matos, Erica Naomi [3 ,4 ,5 ]
da Costa, Marcio Reis [3 ]
Takahashi, Fernanda [5 ,6 ]
Rezende, Marcelo Cruz [7 ]
Kanomata, Leticia Barrios [8 ]
Pradebon Locatelli, Elisangela Possebon [5 ]
Finotti, Leandro Tavares [3 ,5 ]
Maciel Maegawa, Flavia Kamy [1 ]
Ribeiro Rondon, Rosa Maria [9 ]
Machado, Natalia Pereira [3 ,6 ,10 ]
Ayres Tavares do Couto, Flavia Midori Arakaki [6 ]
Alves de Figueiredo, Tulia Peixoto [2 ]
Ovidio, Raphael Antonio [11 ]
da Costa, Izaias Pereira [3 ,9 ]
机构
[1] Univ Fed Mato Grosso do Sul UFMS, Campo Grande, MS, Brazil
[2] Hosp Reg Mato Grosso do Sul, Serv Reumatol, Campo Grande, MS, Brazil
[3] Univ Fed Mato Grosso do Sul UFMS, Univ Hosp, Serv Reumatol, Campo Grande, MS, Brazil
[4] Univ Brasilia UnB, Brasilia, DF, Brazil
[5] Prefeitura Municipal Campo Grande, Ambulatorio Especialidades Med, Campo Grande, MS, Brazil
[6] Univ Anhanguera Uniderp, Fac Med, Ambulatorio Especialidades Med, Campo Grande, MS, Brazil
[7] Santa Casa Campo Grande, Serv Reumatol, Campo Grande, MS, Brazil
[8] Caixa Assistencia Aos Serv Mato Grosso do Sul Cas, Ambulatorio Especialidades Med, Coxim, MS, Brazil
[9] Univ Sao Paulo, Sao Paulo, SP, Brazil
[10] Univ Fed Sao Paulo Unifesp, Sao Paulo, SP, Brazil
[11] UFGD, Univ Hosp, Serv Reumatol, Dourados, MS, Brazil
关键词
Systemic sclerosis; Scleroderma; Incidence; Prevalence; Brazil; GERMAN NETWORK; EPIDEMIOLOGY; SCLERODERMA; SURVIVAL; AUTOANTIBODIES; ASSOCIATION; ANTIBODIES; FREQUENCY; MANIFESTATIONS; CLASSIFICATION;
D O I
10.1016/j.rbr.2016.05.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Systemic sclerosis (SSc) is an autoimmune disease which shows extreme heterogeneity in its clinical presentation and that follows a variable and unpredictable course. Although some discrepancies in the incidence and prevalence rates between geographical regions may reflect methodological differences in the definition and verification of cases, they may also reflect true local differences. Objectives: To determine the prevalence and incidence of SSc in the city of Campo Grande, state capital of Mato Grosso do Sul (MS), Brazil, during the period from January to December 2014. Methods: All health care services of the city of Campo Grande - MS with attending in the specialty of Rheumatology were invited to participate in the study through a standardized form of clinical and socio-demographic assessment. Physicians of any specialty could report a suspected case of SSc, but necessarily the definitive diagnosis should be established by a rheumatologist, in order to warrant the standardization of diagnostic criteria and exclusion of other diseases resembling SSc. At the end of the study, 15 rheumatologists reported that they attended patients with SSc and sent the completed forms containing epidemiological data of patients. Results: The incidence rate of SSc in Campo Grande for the year 2014 was 11.9 per million inhabitants and the prevalence rate was 105.6 per million inhabitants. SSc patients were mostly women, white, with a mean age of 50.58 years, showing the limited form of the disease with a mean duration of the disease of 8.19 years. Regarding laboratory tests, 94.4% were positive for ANA, 41.6% for ACA and 19.1% for anti-Sc170; anti-RNA Polymerase III was performed in 37 patients, with 16.2% positive. Conclusions: The city of Campo Grande, the state capital of MS, presented a lower incidence/prevalence of SSc in comparison with those numbers found in US studies and close to European studies' data. Published by Elsevier Editora Ltda.
引用
收藏
页码:107 / 114
页数:8
相关论文
共 40 条
[21]   Prevalence of systemic sclerosis in a French multi-ethnic county [J].
Le Guern, V ;
Mahr, A ;
Mouthon, L ;
Jeanneret, D ;
Carzon, M ;
Guillevin, L .
RHEUMATOLOGY, 2004, 43 (09) :1129-1137
[22]  
LeRoy EC, 2001, J RHEUMATOL, V28, P1573
[23]  
Lo Monaco A, 2011, CLIN EXP RHEUMATOL, V29, pS10
[24]   Classification and epidemiology of scleroderma [J].
Mayes, MD .
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 1998, 17 (01) :22-26
[25]   Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population [J].
Mayes, MD ;
Lacey, JV ;
Beebe-Dimmer, J ;
Gillespie, BW ;
Cooper, B ;
Laing, TJ ;
Schottenfeld, D .
ARTHRITIS AND RHEUMATISM, 2003, 48 (08) :2246-2255
[26]   Scleroderma epidemiology [J].
Mayes, MD .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2003, 29 (02) :239-+
[27]   Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features [J].
Mierau, Rudolf ;
Moinzadeh, Pia ;
Riemekasten, Gabriela ;
Melchers, Inga ;
Meurer, Michael ;
Reichenberger, Frank ;
Buslau, Michael ;
Worm, Margitta ;
Blank, Norbert ;
Hein, Rueiger ;
Mueller-Ladner, Ulf ;
Kuhn, Annegret ;
Sunderkoetter, Cord ;
Juche, Aaron ;
Pfeiffer, Christiane ;
Fiehn, Christoph ;
Sticherling, Michael ;
Lehmann, Percy ;
Stadler, Rudolf ;
Schulze-Lohoff, Eckhard ;
Seitz, Cornelia ;
Foeldvari, Ivan ;
Krieg, Thomas ;
Genth, Ekkehard ;
Hunzelmann, Nicolas .
ARTHRITIS RESEARCH & THERAPY, 2011, 13 (05)
[28]  
Müller Carolina de Souza, 2011, Rev. Bras. Reumatol., V51, P319, DOI 10.1590/S0482-50042011000400004
[29]  
Nietert PJ, 2006, J RHEUMATOL, V33, P263
[30]   Geoepidemiology of systemic sclerosis [J].
Ranque, Brigitte ;
Mouthon, Luc .
AUTOIMMUNITY REVIEWS, 2010, 9 (05) :A311-A318